Clinical Trial Update: Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial compares two first-line chemotherapy regimens for advanced esophageal squamous cell carcinoma: docetaxel plus cisplatin versus 5-fluorouracil pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophagus Cancer, Chemotherapy Effects | Phase 3 | Status: UNKNOWN